Full Breakdown
New Structural Snapshots Reveal DNA Repair Mechanism Linked to BRCA Mutations
4/28/2026, 12:33:57 AM
New Structural Snapshots Reveal DNA Repair Mechanism
Scientists at Ohio State’s College of Medicine and Georgia Tech captured the most detailed images yet of Mgm101, a yeast homolog of human RAD52. Using native mass spectrometry, mass photometry, and cryo-EM, they visualized three stages of single-strand annealing: a 19-mer ring bound to one DNA strand (substrate), a duplex intermediate with a second strand, and the final double-helix product.
Background & Key Contributors
BRCA1/2 loss forces cancer cells to depend on RAD52-mediated single-strand annealing for DNA repair. The work was led by Charles Bell (Ohio State) and Vicki Wysocki (Georgia Tech), with co-first authors Carter Wheat and Zihao Qi. Funding from the NSF and NIH supported the study, which appeared as a Breakthrough Article in *Nucleic Acids Research* (April 27, 2026).
Structural Findings
Mass photometry confirmed that Mgm101 forms a precise 19-unit ring that scaffolds DNA. Cryo-EM at near-atomic resolution captured the substrate, a previously unseen duplex intermediate with exposed bases, and the final B-form product. The data show a single ring suffices for annealing, supporting a conserved cis mechanism.
Therapeutic Implications
Targeting RAD52-mediated single-strand annealing could selectively kill BRCA-deficient cancer cells and overcome resistance to existing therapies. The newly resolved substrate, duplex intermediate, and product structures define concrete molecular surfaces for small-molecule inhibitor design.
Official Statements & Institutional Responses
Charles Bell said the images guide drug-development strategies, and Vicki Wysocki described the ring as a template for aligning DNA strands. Both investigators plan to extend the workflow to human RAD52. The NSF and NIH emphasized their support for research that connects structural biology with cancer therapeutics.
Remaining Uncertainties & Scientific Debate
The authors stress that the mechanism remains a proposed model; the snapshots do not capture every transient step. Moreover, the duplex intermediate has not yet been visualized in human RAD52, leaving open questions about species-specific variations.
Verbatim Quotes
- “This focuses our strategies for drug development.” — Charles Bell, Professor of Biological Chemistry and Pharmacology
- “This ring is sitting there as a template so that the first strand of the DNA can come down, and then the second strand comes on and starts being annealed to the first strand,” — Vicki Wysocki, Professor Emerita, Georgia Institute of Technology
- “RAD52 high-resolution structures have been determined with single-stranded DNA, but not with the two DNAs that it’s trying to anneal,” — Charles Bell
- “Here, we have more of the states along the full pathway from substrate, to intermediate and product. And the duplex intermediate is a conformation that’s never been seen before – when the protein binds the first DNA around the ring, it’s bound only by its sugar-phosphate backbone, with the nucleotide bases pointing up and fully exposed and separated, so that they can be searched. It’s extended, it’s completely unwound, and it’s circular.” — Charles Bell
What’s Next
The team will apply the same cryo-EM and mass-spectrometry pipeline to human RAD52, aiming to capture the duplex intermediate and map DNA-protein contacts. Parallel screening will test compounds that disrupt the 19-mer ring or block exposed DNA bases, moving toward preclinical evaluation of RAD52-targeted inhibitors.
